MedTrace Logo

Comparison of Blood and Crystalloid Cardioplegia

NCT01941420 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2013-09-13

No results posted yet for this study

Summary

The investigators decided to make a study with a cohort of patients as homogenous as possible with a cross clamp time around 70 min. Adult patients with a severe aortic stenoses without any other significant heart disease was included in our prospective randomised study. This group of patients was chosen for two reasons. First, these patients have left ventricular hypertrophy making the myocardium vulnerable to ischemia, secondly the investigators wanted to avoid the possible confounding effect of ischemia found in patients with variable degrees of coronary artery disease. Therefore, patients with additional significant coronary artery disease (≥ 50% stenoses) were excluded from the study.

Conditions

  • Aortic Stenosis
  • Myocardial Protection

Sponsors & Collaborators

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Theis Tönnessen, prof.Dr.Med · Thoraxkirurgisk avdeling UUS

  • Björn Braathen, med.doc · Thoraxkirurgisk avdeling UUS

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-11-30
Primary Completion
2009-02-28
Completion
2012-09-30

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01941420 on ClinicalTrials.gov